Trial Profile
A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jun 2016
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine
- Indications Opioid-related disorders
- Focus Therapeutic Use
- Acronyms SWITCH
- Sponsors Schering-Plough
- 02 Dec 2012 Company changed from Schering Plough to Reckitt Benckiser as reported by ClinicalTrials.gov.
- 26 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.